Goldman Sachs analyst Corinne Jenkins raised the price target on Geron Corporation (NASDAQ: GERN) to $6.00 (from $5.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Geron Corporation (GERN) PT Raised to $7 at StifelJune 10, 2024 8:14 AM Barclays Starts Geron Corporation (GERN) at OverweightJune 10, 2024 8:09 AM Form 4 GERON CORP For: Jun 06 Filed by: GRETHLEIN ANDREW JJune 7, 2024 4:10 PM Form 4 GERON CORP For: Jun 06 Filed by: Feller FayeJune 7, 2024 4:10 PM Form 4 GERON CORP For: Jun 06 Filed by: Kapur AnilJune 7, 2024 4:10 PM Form 4 GERON CORP For: Jun 06 Filed by: ROBERTSON MICHELLEJune 7, 2024 4:10 PM Form 4 GERON CORP For: Jun 06 Filed by: Samuels Scott AlanJune 7, 2024 4:10 PM Form 4 GERON CORP For: Jun 06 Filed by: SCARLETT JOHN AJune 7, 2024 4:10 PM Form 8-K GERON CORP For: Jun 06June 7, 2024 4:04 PM TD Cowen Reiterates Buy Rating on Geron Corporation (GERN)June 7, 2024 2:02 PM Midday movers: GameStop, DocuSign fall; Lyft, Geron riseJune 7, 2024 7:58 AM Geron surges after winning first US FDA approval for blood disorder drugJune 7, 2024 6:34 AM Geron Corp (GERN) Announces FDA Approval of RYTELOJune 6, 2024 9:59 PM